Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Pfizer,Axitinib,"Renal cell carcinoma, metastatic, clear cell, 2nd line",Axitinib (Inlyta),,Community and Hospital,Oncology Agents and Immunosuppressants
